Established in 2015, the Center for Vaccines and Immunology (CVI) provides an environment for world-class research and training in immunology. The CVI is advancing fundamental and translational immunological knowledge to develop new vaccines and therapies for infectious diseases and other immunity-related diseases and syndromes.
The University of Georgia officially launched its chapter of the National Academy of Inventors (NAI) during a kickoff event on April 28. The chapter will celebrate and support the achievements of inventors at UGA. UGA’s chapter of the National Academy of Inventors launches with 31 founding members composed of faculty from […]
Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model
NPJ Vaccines. June 2025
HaloPROTAC3 does not trigger the degradation of the halotagged parasitophorous vacuole membrane protein UIS4 during Plasmodium liver stage development
Sci Rep. May 2025
Receptor-binding specificity of a bovine influenza A virus
Nature. April 2025
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages
Sci Adv. March 2025
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates
J Virol. March 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants
J Virol. March 2025
